| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26159-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11596 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11501 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26683-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26606-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-95271 | |||
![Immunocytochemistry/Immunofluorescence: LYVE-1 Antibody (11C11) [NBP3-26159] - Staining of HepG2 with LYVE-1 Antibody (11C11) at 1:25, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 505-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26159_rabbit-lyve-1-mab-11c11-28220241249369.jpg "Immunocytochemistry/Immunofluorescence: LYVE-1 Antibody (11C11) [NBP3-26159] - Staining of HepG2 with LYVE-1 Antibody (11C11) at 1:25, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 505-conjugated Goat Anti-Rabbit IgG (H+L).")
![Flow Cytometry: LYVE-1 Antibody (11C11) [NBP3-26159] - Overlay Peak curve showing HepG2 cells stained with LYVE-1 Antibody (11C11) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26159_rabbit-lyve-1-mab-11c11-28220241418361.jpg)
![Western Blot: TfR (Transferrin R) Antibody (TFRC/1149) [NBP2-45008] - Western Blot of PC3 cell lysate using TfR (Transferrin R) Antibody (TFRC/1149)](http://images.novusbio.com/fullsize/TfR-Transferrin-R-Antibody-TFRC-1149-Western-Blot-NBP2-45008-img0001.jpg "Western Blot: TfR (Transferrin R) Antibody (TFRC/1149) [NBP2-45008] - Western Blot of PC3 cell lysate using TfR (Transferrin R) Antibody (TFRC/1149)")
![Western Blot: RFX1 Antibody [NBP1-52653] - Whole cell lysate (1 mg for IP, 20% of IP loaded) from HeLa cells. Antibodies: Affinity purified rabbit anti-RFX1 antibody used for IP at 6 mcg/mg lysate. RFX1 was also immunoprecipitated by rabbit anti-RFX1 antibodies NBP1-52652 and NBP1-52654, which recognize other epitopes.](http://images.novusbio.com/fullsize/RFX1-Antibody-Western-Blot-NBP1-52653-img0002.jpg "<b>Independent Antibodies Validation. </b>Western Blot: RFX1 Antibody [NBP1-52653] - Whole cell lysate (1 mg for IP, 20% of IP loaded) from HeLa cells. Antibodies: Affinity purified rabbit anti-RFX1 antibody used for IP at 6 mcg/mg lysate. RFX1 was also immunoprecipitated by rabbit anti-RFX1 antibodies NBP1-52652 and NBP1-52654, which recognize other epitopes.")
![Immunohistochemistry-Paraffin: S100A9 Antibody (CPT/1028) [NBP2-44912] - Human Tonsil stained with Calprotectin Monoclonal Antibody (CPT/1028)](http://images.novusbio.com/fullsize/S100A9-Antibody-CPT-1028-Immunohistochemistry-Paraffin-NBP2-44912-img0001.jpg "Immunohistochemistry-Paraffin: S100A9 Antibody (CPT/1028) [NBP2-44912] - Human Tonsil stained with Calprotectin Monoclonal Antibody (CPT/1028)")
![Immunohistochemistry: CD36 Antibody (13B12) [NBP3-26683] - Image of CD36 Antibody (13B12) diluted at 1:100 and staining in paraffin-embedded human spleen tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.25% DAB.](http://images.novusbio.com/fullsize/nbp3-26683_rabbit-cd36-mab-13b12-2622024152240.jpg "Immunohistochemistry: CD36 Antibody (13B12) [NBP3-26683] - Image of CD36 Antibody (13B12) diluted at 1:100 and staining in paraffin-embedded human spleen tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.25% DAB.")
![Immunohistochemistry: CD36 Antibody (13B12) [NBP3-26683] - Image of CD36 Antibody (13B12) diluted at 1:100 and staining in paraffin-embedded human spleen tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.25% DAB.](http://images.novusbio.com/fullsize/nbp3-26683_rabbit-cd36-mab-13b12-272202485635.jpg)
![Immunohistochemistry: EGF Antibody (18B12) [NBP3-26606] - Image of EGF Antibody (18B12) diluted at 1:100 and staining in paraffin-embedded human skin tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.66% DAB.](http://images.novusbio.com/fullsize/nbp3-26606_rabbit-egf-mab-18b12-262202414225218.jpg "Immunohistochemistry: EGF Antibody (18B12) [NBP3-26606] - Image of EGF Antibody (18B12) diluted at 1:100 and staining in paraffin-embedded human skin tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.66% DAB.")
![Flow Cytometry: EGF Antibody (18B12) [NBP3-26606] - Overlay Peak curve showing SH-SY5Y cells stained with EGF Antibody (18B12) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26606_rabbit-egf-mab-18b12-282202414183693.jpg)